Clinical Trial Update: Efficacy and Safety Study of Nab-Paclitaxel Combined With Cisplatin in Second or Later-Line Treatment in Advanced Biliary Tract Cancers [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nab-paclitaxel with cisplatin in advanced biliary tract cancers; efficacy and safety updates are reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Cholangiocarcinoma
• Gallbladder Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Henan Provincial People's Hospital | Conditions: Advanced Biliary Tract Cancers | Phase 2 | Status: UNKNOWN